DOTmed September 24, 2021
Ceribell is a company that is changing what it means to monitor brain activity. We sat down with the company’s chief medical officer, Dr. Diku Mandavia, to learn more about how innovations in artificial intelligence can change what’s possible at the point of care, particularly for stroke patients, and what it means for the providers who utilize the technology.
HealthCare Business News: We covered Ceribell for one of its funding rounds, and we’re intrigued to see that your brain monitors are being adopted for both the ER and ICU. From our research it seems like you are the only company in the market who has these point-of-care monitors, is that correct?
Dr. Diku Mandavia: Yes, that’s correct. Ceribell has developed...
Today's Sponsors
Today's Sponsor